Black Diamond Therapeutics (BDTX) Profit After Tax (2018 - 2021)
Historic Profit After Tax for Black Diamond Therapeutics (BDTX) over the last 4 years, with Q4 2021 value amounting to -$25.9 million.
- Black Diamond Therapeutics' Profit After Tax fell 1432.42% to -$25.9 million in Q4 2021 from the same period last year, while for Dec 2021 it was -$117.9 million, marking a year-over-year decrease of 7533.68%. This contributed to the annual value of -$125.6 million for FY2021, which is 8674.87% down from last year.
- Per Black Diamond Therapeutics' latest filing, its Profit After Tax stood at -$25.9 million for Q4 2021, which was down 1432.42% from -$35.1 million recorded in Q3 2021.
- Over the past 5 years, Black Diamond Therapeutics' Profit After Tax peaked at -$3.1 million during Q4 2018, and registered a low of -$35.1 million during Q3 2021.
- In the last 4 years, Black Diamond Therapeutics' Profit After Tax had a median value of -$13.4 million in 2019 and averaged -$16.7 million.
- Its Profit After Tax has fluctuated over the past 5 years, first crashed by 22208.09% in 2019, then plummeted by 1432.42% in 2021.
- Black Diamond Therapeutics' Profit After Tax (Quarter) stood at -$3.1 million in 2018, then crashed by 222.08% to -$9.9 million in 2019, then crashed by 129.12% to -$22.6 million in 2020, then dropped by 14.32% to -$25.9 million in 2021.
- Its Profit After Tax stands at -$25.9 million for Q4 2021, versus -$35.1 million for Q3 2021 and -$34.4 million for Q2 2021.